Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT921 for Moderate to Severe Submental Fat
NCT05195112Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Nuviju in submental fat, sponsored by Medytox Inc.. Started Dec 2021; status: completed.
02
Drugs
Nuviju
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT05195112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195112.